We are investigating a new drug for patients with metastatic HR+/HER2- breast cancer and other advanced solid tumors. The study aims to evaluate its safety and early signs of effectiveness, both alone and with other treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced or metastatic solid tumors refer to cancers that have spread from their original site to other parts of the body. This includes various types of cancers such as hormone receptor positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer, which can significantly impact treatment options and prognosis.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.